Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5795553 | 6653917 | F | 5795553-5 | 20080501 | 20080618 | 20080630 | EXP | PHHY2008JP08582 | NOVARTIS PHARMACEUTICALS CORP. | M | Y | 67 | KG | 20080630 | OT | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5795553 | 1010112651 | PS | ZOMETA | 1 | INTRAVENOUS | 4 MG, UNK | 21223 | ||||
| 5795553 | 1010112652 | SS | ESTRACYT | 2 | ORAL | 2 DF, DAILY | |||||
| 5795553 | 1010112653 | C | URIEF | 2 | ORAL | 8 MG, UNK | |||||
| 5795553 | 1010112654 | C | FOSAMAX | 1 | ORAL | 1 DF, UNK |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5795553 | 1010112651 | METASTASES TO BONE |
| 5795553 | 1010112652 | PROSTATE CANCER |
| 5795553 | 1010112653 | BENIGN PROSTATIC HYPERPLASIA |
| 5795553 | 1010112654 | OSTEOPOROSIS |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5795553 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 5795553 | CARDIAC FAILURE CONGESTIVE |
| 5795553 | CARDIOMEGALY |
| 5795553 | DYSPNOEA |
| 5795553 | HAEMATOCRIT DECREASED |
| 5795553 | HAEMOGLOBIN DECREASED |
| 5795553 | PLEURAL EFFUSION |
| 5795553 | WHITE BLOOD CELL COUNT INCREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5795553 | 1010112651 | 20080512 | 20080512 | 1 | DAY |
| 5795553 | 1010112652 | 20060731 | |||
| 5795553 | 1010112653 | 20080430 | |||
| 5795553 | 1010112654 | 20060410 |